GSK2033, CAS 1221277-90-2

Formulation: A solid

Formal Name: 2,4,6-trimethyl-N-[[3'-(methylsulfonyl)[1,1'-biphenyl]-4-yl]methyl]-N-[[5-(trifluoromethyl)-2-furanyl]methyl]-benzenesulfonamide

Purity: ≥98%

Formula Markup: C29H28F3NO5S2

Formula Weight: 591,7

Shelf life (days): 1460

CAS Number: 1221277-90-2

Notes: GSK2033 is an antagonist of liver X receptor α (LXRα) and LXRβ (IC50s = 0.1 and 0.398 µM, respectively) that has no agonist activity in an LXR transactivation assay.{36795} It inhibits LXR agonist-induced and basal expression of the LXR target genes ATP-binding cassette transporter 1 (ABCA1) and sterol regulatory element binding protein 1c (SREBP-1c) in THP-1 and HepG2 cells, respectively. However, GSK2033 binds promiscuously to a variety of nuclear receptors including RORγ, RXRα, ERα, and ERβ in a nuclear receptor specificity assay in HEK293 cells and, in a mouse model of non-alcoholic fatty liver disease (NAFLD), it induces the expression of fatty acid synthase and SREBP-1.{36796}

• Artikelnummer: CAY25443-5
• Hersteller: Cayman Chemical
• Hersteller Artikelnummer: 25443-5
• Green Labware: Nein
• Verpackungseinheit: 5 mg
• Mengeneinheit: STK